Eton Pharmaceuticals Inc

General ticker "ETON" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $319.5M

Eton Pharmaceuticals Inc follows the US Stock Market performance with the rate: 47.1%.

Estimated limits based on current volatility of 3.3%: low 12.12$, high 12.94$

Factors to consider:

  • Current price 117.2% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.75$, 5.79$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.70$, 5.72$]

Financial Metrics affecting the ETON estimates:

  • Negative: Non-GAAP EPS, $ of -0.06 <= 0.10
  • Negative: Operating profit margin, % of -3.63 <= 1.03
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -15.01 <= 1.31
  • Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85

Similar symbols

Short-term ETON quotes

Long-term ETON plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $21.83MM $21.25MM $31.64MM
Operating Expenses $23.33MM $29.51MM $32.83MM
Operating Income $-1.50MM $-8.26MM $-1.19MM
Non-Operating Income $-0.46MM $-0.76MM $0.50MM
Interest Expense $1.01MM $0.76MM $0.00MM
R&D Expense $6.24MM $4.00MM $3.32MM
Income(Loss) $-1.96MM $-9.02MM $-0.69MM
Taxes $0.00MM $0.00MM $0.25MM
Profit(Loss) $-1.96MM $-9.02MM $-0.94MM
Stockholders Equity $17.63MM $13.08MM $15.48MM
Inventory $0.55MM $0.56MM $0.91MM
Assets $27.46MM $25.03MM $31.74MM
Operating Cash Flow $-4.72MM $4.82MM $6.82MM
Capital expenditure $3.26MM $2.79MM $0.78MM
Investing Cash Flow $-2.56MM $-2.79MM $-0.78MM
Financing Cash Flow $0.39MM $-0.13MM $-0.96MM
Earnings Per Share* $-0.12 $-0.39 $-0.04

* EPS are Split Adjusted, recent splits may be reflected with a delay.